Sanofi: waiting period expires for Provention Bio
On March 24, Sanofi launched a tender offer to acquire all of the outstanding common shares of Provention Bio, at a price of $25 per share. The offer will expire on the evening of April 26, but may be extended.
Closing of the offer is subject to various conditions, including the tender of a certain number of shares which, combined with shares already held by Sanofi and its subsidiaries, represent at least a majority of the outstanding shares.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction